NCT01025284 2019-09-17A Study for Participants With Small-Cell Lung CancerEli Lilly and CompanyPhase 2 Completed64 enrolled 18 charts
NCT00862134 2013-01-10Randomized, Multi-center, Open-label, Study of PR104 Versus PR104/Docetaxel in Non-Small Cell Lung Cancer (NSCLC)Proacta, IncorporatedPhase 2 Terminated42 enrolled 11 charts